Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions. - Wikidata - wikimedia - TriplyDB

Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

http://www.wikidata.org/entity/Q37367749

about

Role of redoximiRs in fibrogenesis Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes Glycation of extracellular matrix proteins impairs migration of immune cells.Modification of collagen by 3-deoxyglucosone alters wound healing through differential regulation of p38 MAP kinase.Glucose autoxidation induces functional damage to proteins via modification of critical arginine residues Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Hypohalous acids contribute to renal extracellular matrix damage in experimental diabetes Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans.Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.Inhibition to DRP1 translocation can mitigate p38 MAPK-signaling pathway activation in GMC induced by hyperglycemia.Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney.

P2860

Q26776555-3D988F16-9E2B-4A71-AAAA-284E537F40F7 Q26865565-DBDA489E-FFD5-4CD0-AD8F-DCB6B8BF3BE6 Q30317492-A84AED02-D4EB-4839-8FB9-FCB7EC02D96A Q33900674-2A8B6F80-72EB-4746-85F7-25A8459D408D Q35118391-82FEB869-ED14-4FC2-A572-B1DFF94854C1 Q35255473-CD475766-9684-48A9-AB65-8BB62128C0AE Q35630838-335CF4A3-D8BC-403F-ACAF-5A27E524B65D Q38150990-5C8E5ACB-D2EB-45EA-A57B-2AAAF0C0C807 Q38740309-CA199A56-03E5-4015-9AF1-47F44AFACAAD Q38911361-F79AE8D7-EF28-4258-870A-EC3F459CF379 Q38956425-B056D6AA-F3DA-4736-8329-C446C24EB39E Q44998621-AA4E55FF-1EB5-460E-A408-CD38FB805200 Q51636281-92043C9A-12EB-45B5-8A1D-6D5B8FA82EDA Q52952699-2C10B27B-1E88-47A1-BD5E-68CEC555D14B Q53204966-496509C8-1CDE-4D32-A791-267B9CC26836

P2860

Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

http://www.wikidata.org/entity/Q37367749

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modification of collagen IV by ...... inct mesangial cell functions.

@en

Modification of collagen IV by ...... inct mesangial cell functions.

@nl

type

label

Modification of collagen IV by ...... inct mesangial cell functions.

@en

Modification of collagen IV by ...... inct mesangial cell functions.

@nl

prefLabel

Modification of collagen IV by ...... inct mesangial cell functions.

@en

Modification of collagen IV by ...... inct mesangial cell functions.

@nl

P1433

Q37367749-5D62628E-B6C1-42BB-85C9-7984C21DFAB0

P1476

Q37367749-AF994FEE-3F60-4ABD-965E-1B7779F3A772

P2093

Q37367749-07F15537-A64C-4DD8-A0F2-295B80F0E3B2

Q37367749-36769EEA-DBAA-4FE1-9AA8-5659795F7028

Q37367749-3870529A-29AB-4F78-B89E-5ED6AEB6F6FE

Q37367749-607484B7-019C-4510-923E-6009999825E4

Q37367749-707309F3-C654-43E6-B3CE-91FAC9C075C4

Q37367749-BB625890-FD1C-449A-86AC-1EFE5E44B025

Q37367749-D1FEA4A8-2B1D-4FC2-9909-6C15A85E3B74

Q37367749-F693EB6B-98D5-43FD-B154-8D18AB805196

P2860

Q37367749-06325AAB-87D3-4275-91D1-8AC991CFA3FD

Q37367749-07618C34-A166-48DB-83E1-6A22E6C85CA4

Q37367749-0E9741CB-1CD6-4019-82C8-78D62FC91D31

Q37367749-1720A11B-E9B9-4F34-A437-16ED64D89291

Q37367749-21FD1458-578B-4275-9947-60C78D8DF0A9

Q37367749-28310D55-282F-4281-95BB-9966B152DF0A

Q37367749-28A0BDA1-789F-4B7F-A0F3-5F591DA00EE8

Q37367749-3B856CEF-37C0-4726-A614-70603BA16179

Q37367749-46435B5C-9579-480D-BDAA-C4B7B4955D0F

Q37367749-46531BD3-8D6E-40ED-9E88-9276F1E1F3A7

P304

Q37367749-C76DB81E-CC91-405D-AE8A-DBACEC4A4366

P31

Q37367749-1756C71D-F407-4247-8834-DC3158A2972B

P356

Q37367749-85E3EE36-9F8E-450F-8EA1-366EDAECC801

P433

Q37367749-D6182126-034A-4539-9905-4E82BBE77165

P478

Q37367749-6AD89BD4-BFE9-411E-B045-E2C0609DA0C6

P50

Q37367749-B6F63644-9941-44C6-B09F-B1AF0A38370F

P577

Q37367749-9A0CBDC9-1265-4B74-83F7-EAAE3E2B58C1

P5875

Q37367749-E97BB84A-5D3C-417C-A927-8B7348CE70AE

P698

Q37367749-0F307754-C783-4D09-ACFC-FC5EF0A01C59

P921

Q37367749-04760111-9583-4f1e-a569-a6287afc2064

P932

Q37367749-5B8904FE-16CD-448D-A6EE-D3B40225BCE4

P356

P1433

Journal of the American Society of Nephrology

P1476

Modification of collagen IV by ...... tinct mesangial cell functions

@en

P2093

Ambra Pozzi

http://www.w3.org/2001/XMLSchema#string

Corina Borza

http://www.w3.org/2001/XMLSchema#string

Dong Chen

http://www.w3.org/2001/XMLSchema#string

Nada Bulus

http://www.w3.org/2001/XMLSchema#string

Paul Voziyan

http://www.w3.org/2001/XMLSchema#string

Peale Chuang

http://www.w3.org/2001/XMLSchema#string

Roy Zent

http://www.w3.org/2001/XMLSchema#string

Sergei Chetyrkin

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution"

The pathobiology of diabetic complications: a unifying mechanism

Molecular mechanisms of diabetic renal hypertrophy.

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

Overview of glucose signaling in mesangial cells in diabetic nephropathy.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine.

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.

P304

2119-2125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008080900

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Billy G. Hudson

P577

2009-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26676527

http://www.w3.org/2001/XMLSchema#string

P698

19608705

http://www.w3.org/2001/XMLSchema#string

P921

P932

2754111

http://www.w3.org/2001/XMLSchema#string